These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 35016140)

  • 41. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
    Pruthi H; Muthu V; Bhujade H; Sharma A; Baloji A; Ratnakara RG; Bal A; Singh H; Sandhu MS; Negi S; Chakrabarti A; Singhal M
    Mycopathologia; 2022 Feb; 187(1):31-37. PubMed ID: 34936060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of Iron Chelators in Mucormycosis.
    Mahalmani V; Sarma P; Prakash A; Medhi B
    Indian J Pharmacol; 2021; 53(4):261-263. PubMed ID: 34414902
    [No Abstract]   [Full Text] [Related]  

  • 44. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Black Fungus Complicated with COVID-19 in a Man with Underlying Non-Hodgkin's Lymphoma.
    Nelwan EJ; Tunjungputri RN; Wardani RS; Wahyuningsih R
    Acta Med Indones; 2021 Jul; 53(3):349-351. PubMed ID: 34611076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy.
    Bhardwaj A; Roy V
    Indian J Pharmacol; 2021; 53(5):415-416. PubMed ID: 34854413
    [No Abstract]   [Full Text] [Related]  

  • 47. Cutaneous mucormycosis: an unusual cause of decompensation in a patient with ethanol-related cirrhosis with COVID-19 exposure.
    Menezes S; Kumar JS; Rudra OS; Nagral A
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35140094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [COVID-19 associated mucormycosis. A case in Argentina].
    Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
    Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucormycosis, conflicts and COVID-19: A deadly recipe for the fragile health system of Afghanistan.
    Essar MY; Khan H; Babar MS; Hasan MM; Rackimuthu S; Dos Santos Costa AC; Ahmad S; Nemat A
    Int J Health Plann Manage; 2022 Jan; 37(1):543-546. PubMed ID: 34333804
    [No Abstract]   [Full Text] [Related]  

  • 51. Mixed Infections (Mucormycosis, Actinomycosis and Candidiasis) Leading to Maxillary Osteomyelitis in a Diabetic Mellitus Patient in Post COVID Phase: First Case Report.
    Jawanda MK; Narula R; Gupta S; Sharma V; Sidhu SK; Kaur N
    Acta Medica (Hradec Kralove); 2021; 64(4):218-223. PubMed ID: 35285444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute necrosis of the maxilla due to mucormycosis.
    Gosavi DK
    J Laryngol Otol; 1978 Mar; 92(3):365-9. PubMed ID: 632667
    [No Abstract]   [Full Text] [Related]  

  • 53. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.
    Pasero D; Sanna S; Liperi C; Piredda D; Branca GP; Casadio L; Simeo R; Buselli A; Rizzo D; Bussu F; Rubino S; Terragni P
    Infection; 2021 Oct; 49(5):1055-1060. PubMed ID: 33331988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis.
    Arora N; Gudipati A; Kundu R; Prabhakar N; Suri V; Malhotra P; Jain A
    Lancet Infect Dis; 2021 Nov; 21(11):1611. PubMed ID: 34717815
    [No Abstract]   [Full Text] [Related]  

  • 56. Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit.
    Mulakavalupil B; Vaity C; Joshi S; Misra A; Pandit RA
    Diabetes Metab Syndr; 2021; 15(4):102169. PubMed ID: 34198110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric Mucormycosis and COVID-19.
    Yadav S
    J Contemp Dent Pract; 2021 Aug; 22(8):855. PubMed ID: 34753834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: Clinico-radiological features.
    Rao R; Shetty AP; Nagesh CP
    Indian J Ophthalmol; 2021 Jun; 69(6):1627-1630. PubMed ID: 34011758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19-associated mucormycosis: Preliminary report from a tertiary eye care centre.
    Walia S; Bhaisare V; Rawat P; Kori N; Sharma M; Gupta N; Urdhwareshwar S; Thakur S; Arya N
    Indian J Ophthalmol; 2021 Dec; 69(12):3685-3689. PubMed ID: 34827023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mucormycosis in COVID-19 patients.
    Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
    Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.